12 New Protocols for Fabry Disease Diagnosis in 2026 Enhancing Early Detection through Universal Newborn Screening
In 2026, the clinical landscape for identifying inherited enzyme deficiency has shifted toward universal newborn screening as a primary standard. This genetic metabolic disorder, characterized by the buildup of globotriaosylceramide, often remains undetected for decades, leading to irreversible organ damage. By implementing advanced...